Dr. Stefan Sarafianos, a professor of Molecular Microbiology and Immunology at the University of Missouri, was recently awarded a research grant of $3 million from the National Institutes of Health to develop new drugs to treat Hepatitis B (HBV).
Read More
0 Comments Click here to read/write comments
Tags: Missouri, University of Missouri, Drug Development, MO, NIH award, Midwest Region, MU, Hepatitis B, University of Missouri, Columbia